Alps Group Stock (NASDAQ:ALPS)
Previous Close
$1.19
52W Range
$1.01 - $8.60
50D Avg
$1.81
200D Avg
$3.26
Market Cap
$37.22M
Avg Vol (3M)
$15.79K
Beta
-0.06
Div Yield
-
ALPS Company Profile
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.